MAPT and Alzheimer disease: It has been found to play a rolein the inhibition of tau aggregation and is decreased in AD.42,43 This intronic retention of 18 amino acids leads to the formationof the human-specific W-Tau peptide, which has been the main pointof our research in this work, with a focus on its interaction withhuman PHFs.